 <h1>Gamifant Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>emapalumab</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about emapalumab. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Gamifant.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to emapalumab: intravenous solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, emapalumab (the active ingredient contained in Gamifant) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking emapalumab:</p><p>
<i>More common</i>
</p><ul>
<li>Agitation</li>
<li>back pain</li>
<li>black, tarry stools</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>bloody stools</li>
<li>blurred vision</li>
<li>chest pain, discomfort, or tightness</li>
<li>chills</li>
<li>confusion</li>
<li>cough</li>
<li>decreased awareness or responsiveness</li>
<li>decreased urine</li>
<li>depression</li>
<li>difficult or labored breathing</li>
<li>dry mouth</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>feeling of warmth</li>
<li>fever</li>
<li>headache</li>
<li>hoarseness</li>
<li>hostility</li>
<li>increased thirst</li>
<li>irritability</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>loss of appetite</li>
<li>loss of consciousness</li>
<li>lower back or side pain</li>
<li>mood changes</li>
<li>muscle pain, cramps, or twitching</li>
<li>nausea</li>
<li>nervousness</li>
<li>nosebleed</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>painful or difficult urination</li>
<li>pounding in the ears</li>
<li>rapid weight gain</li>
<li>rapid, shallow breathing</li>
<li>redness of the face, neck, arms and occasionally, upper chest</li>
<li>seizures</li>
<li>severe sleepiness</li>
<li>slow heartbeat</li>
<li>swollen glands</li>
<li>unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness</li>
<li>unusual weight gain or loss</li>
<li>vomiting</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of emapalumab may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Constipation</li>
<li>lack or loss of strength</li>
<li>stomach pain</li>
</ul><p>
<!-- end intravenous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to emapalumab: intravenous solution</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Lymphocytosis (12%)<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Overall infections (NOTE: Reported infections were 41% viral, 35% bacterial, 9% fungal, and 15% not identified) (56%), serious infections (e.g., sepsis, pneumonia, bacteremia, disseminated histoplasmosis, necrotizing fasciitis, viral infections, perforated appendicitis) (32%), cytomegalovirus infection (12%)</p>
<p><b>Common</b> (1% to 10%): Immunogenicity<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Infusion-related reactions (27%)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hypokalemia (15%)</p>
<p><b>Common</b> (1% to 10%): Vomiting<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Acute kidney injury<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Couth (12%), tachypnea (12%)</p>
<p><b>Common</b> (1% to 10%): Dyspnea, epistaxis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pyrexia (24%)</p>
<p><b>Common</b> (1% to 10%): Asthenia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (41%), tachycardia (12%)</p>
<p><b>Common</b> (1% to 10%): Bradycardia, peripheral edema<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (12%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Constipation (15%), abdominal pain (12%), diarrhea (12%)</p>
<p><b>Common</b> (1% to 10%): GI hemorrhage<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Gamifant (emapalumab)." Sobi Inc, Ardmore, PA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Gamifant (emapalumab)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: selective immunosuppressants</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Gamifant &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Hemophagocytic Lymphohistiocytosis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to emapalumab: intravenous solution</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Lymphocytosis (12%)<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Overall infections (NOTE: Reported infections were 41% viral, 35% bacterial, 9% fungal, and 15% not identified) (56%), serious infections (e.g., sepsis, pneumonia, bacteremia, disseminated histoplasmosis, necrotizing fasciitis, viral infections, perforated appendicitis) (32%), cytomegalovirus infection (12%)</p><p><b>Common</b> (1% to 10%): Immunogenicity<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Infusion-related reactions (27%)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hypokalemia (15%)</p><p><b>Common</b> (1% to 10%): Vomiting<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Acute kidney injury<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Couth (12%), tachypnea (12%)</p><p><b>Common</b> (1% to 10%): Dyspnea, epistaxis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pyrexia (24%)</p><p><b>Common</b> (1% to 10%): Asthenia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (41%), tachycardia (12%)</p><p><b>Common</b> (1% to 10%): Bradycardia, peripheral edema<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (12%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Constipation (15%), abdominal pain (12%), diarrhea (12%)</p><p><b>Common</b> (1% to 10%): GI hemorrhage<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Gamifant (emapalumab)." Sobi Inc, Ardmore, PA. </p><h2>More about Gamifant (emapalumab)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: selective immunosuppressants</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Gamifant &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Hemophagocytic Lymphohistiocytosis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>